Global and United States Argatroban Market Research by Company, Type & Application 2013-2025

Publisher Name :
Date: 24-Apr-2018
No. of pages: 89

Summary

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Market Segment as follows: By Type

- Argatroban Powder

- Argatroban Injection

By Application

- Heparin-induced thrombocytopenia (HIT)

- Percutaneous Coronary Intervention

- Cerebral arterial thrombosis

By Company

- Pfizer

- SANDOZ

- GlaxoSmithKline

- fresenius-kabi

- Eagle Pharmaceuticals

- Mitsubishi Tanabe Pharma

- Teva Pharmaceutical Industries

- WEST-WARD

The main contents of the report including:

Section 1: Product definition, type and application, global and United States market overview;

Section 2: Global and United States Market competition by company;

Section 3: Global and United States sales revenue, volume and price by type;

Section 4: Global and United States sales revenue, volume and price by application;

Section 5: United States export and import;

Section 6: Company information, business overview, sales data and product specifications;

Section 7: Industry chain and raw materials;

Section 8: SWOT and Porter's Five Forces;

Section 9: Conclusion.

Global and United States Argatroban Market Research by Company, Type & Application 2013-2025

Table of Contents

1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Argatroban Powder
1.1.2.2 Argatroban Injection
1.1.3 Market by Application
1.1.3.1 Heparin-induced thrombocytopenia (HIT)
1.1.3.2 Percutaneous Coronary Intervention
1.1.3.3 Cerebral arterial thrombosis
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 Global and Regional Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 Global and Regional Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 Global and Regional Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 Regional Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 SANDOZ
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 GlaxoSmithKline
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 fresenius-kabi
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Eagle Pharmaceuticals
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Mitsubishi Tanabe Pharma
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Teva Pharmaceutical Industries
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 WEST-WARD
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion

List of Tables

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of fresenius-kabi
Table Sales Revenue, Volume, Price, Cost and Margin of Eagle Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical Industries
Table Sales Revenue, Volume, Price, Cost and Margin of WEST-WARD

List of Figures

Figure Argatroban Powder Market Size and CAGR 2013-2017 (Million USD)
Figure Argatroban Powder Market Size and CAGR 2013-2017 (Volume)
Figure Argatroban Powder Market Forecast and CAGR 2018-2025 (Million USD)
Figure Argatroban Powder Market Forecast and CAGR 2018-2025 (Volume)
Figure Argatroban Injection Market Size and CAGR 2013-2017 (Million USD)
Figure Argatroban Injection Market Size and CAGR 2013-2017 (Volume)
Figure Argatroban Injection Market Forecast and CAGR 2018-2025 (Million USD)
Figure Argatroban Injection Market Forecast and CAGR 2018-2025 (Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2017 (Million USD)
Figure Heparin-induced thrombocytopenia (HIT) Market Size and CAGR 2013-2017 (Volume)
Figure Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2018-2025 (Million USD)
Figure Heparin-induced thrombocytopenia (HIT) Market Forecast and CAGR 2018-2025 (Volume)
Figure Percutaneous Coronary Intervention Market Size and CAGR 2013-2017 (Million USD)
Figure Percutaneous Coronary Intervention Market Size and CAGR 2013-2017 (Volume)
Figure Percutaneous Coronary Intervention Market Forecast and CAGR 2018-2025 (Million USD)
Figure Percutaneous Coronary Intervention Market Forecast and CAGR 2018-2025 (Volume)
Figure Cerebral arterial thrombosis Market Size and CAGR 2013-2017 (Million USD)
Figure Cerebral arterial thrombosis Market Size and CAGR 2013-2017 (Volume)
Figure Cerebral arterial thrombosis Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cerebral arterial thrombosis Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Argatroban Market Size and CAGR 2013-2017 (Million USD)
Figure Global Argatroban Market Size and CAGR 2013-2017 (Volume)
Figure Global Argatroban Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Argatroban Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Argatroban Market Size and CAGR 2013-2017 (Million USD)
Figure United States Argatroban Market Size and CAGR 2013-2017 (Volume)
Figure United States Argatroban Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Argatroban Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Argatroban SWOT List
Figure Healthcare & Medical Porter's Five Forces
  • Global Antihistamine Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 122
    Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines. Histamine is an immune substance released by body's immune system upon attack by allergens or due to intake of histamine-deficient food, some food items also trigger their excessive production which creates immune response. Scope of the Report: The worldwide market for Antihistamine Drugs is expected to grow at a CAGR of roughly xx% over t......
  • Global Retinal Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Retinal drugs are the medications that are used for the treatment of retinal diseases Scope of the Report: North America dominated the global retinal drugs market in 2017 The worldwide market for Retinal Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Retinal Drugs in global market, especia......
  • Global Preventable Vaccines Market Insights, Forecast to 2025
    Published: 20-Nov-2018        Price: US 3900 Onwards        Pages: 125
    This report studies the global market size of Preventable Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Preventable Vaccines in these regions. This research report categorizes the global Preventable Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, marke......
  • Global Fluconazole Market Insights, Forecast to 2025
    Published: 20-Nov-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Fluconazole in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fluconazole in these regions. This research report categorizes the global Fluconazole market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities an......
  • Global Hyperphosphatemia Drug Market Forecast 2019-2027
    Published: 19-Nov-2018        Price: US 2500 Onwards        Pages: 123
    Key Findings The global hyperphosphatemia drugs market is expected to grow at a CAGR of 16.13% during the forecast period of 2019-2027. The market is expected to be worth $xx million by the year 2027. Increasing prevalence of chronic diseases, unmet medical needs, a high proportion of the elderly population and the rise in public awareness are the major drivers for the hyperphosphatemia drugs market. Market Insights The market segmentation is done on the basis of the......
  • North America Hyperphosphatemia Drug Market Forecast 2019-2027
    Published: 19-Nov-2018        Price: US 1250 Onwards        Pages: 80
    Key Findings The North America hyperphosphatemia drug market is expected to grow at a CAGR of 15.19% over the forecast period. The region is expected to hold the largest share in the market with an anticipated increase in the revenue from $xx million in 2018 to $xx million by 2027. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. Increasing prevalence of these chronic diseases along with unattended medical needs are driving the hype......
  • Europe Hyperphosphatemia Drug Market Forecast 2019-2027
    Published: 19-Nov-2018        Price: US 1250 Onwards        Pages: 81
    Key Findings The Europe hyperphosphatemia drug market is expected to grow at a CAGR of 15.63% during the forecast period of 2019-2027. The market revenue is estimated to increase from $xx million in 2018 to $xx million by the end of 2027. Rising elderly citizenry, altering dietary habits and surging cases of osteoporosis are responsible for the expansion of the hyperphosphatemia drug market. Market Insights The Calcium-based phosphate binder's formulation containing ......
  • Asia Pacific Hyperphosphatemia Drug Market Forecast 2019-2027
    Published: 19-Nov-2018        Price: US 1250 Onwards        Pages: 70
    Key Findings The Asia-Pacific hyperphosphatemia drugs market was worth $xx million in 2018. The market is estimated to grow at a CAGR of 17.37% during the forecast period of 2019-2027 and generate $xx million by the end of 2027. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. The growing prevalence of such chronic diseases, increasing elderly population, unmet medical attention, and the rise in public awareness are the major driver......
  • Global Ranitidine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 116
    Ranitidine is a histamine H2 antagonists and available as both over-the-counter (OTC) and prescription drug, indicated in the treatment of gastroesophageal reflux disease (GERD). Ranitidine decreases the acid production from stomach for up to 12 hours. Also, ranitidine is commonly used in erosive esophagitis, peptide ulcer disease, and Zollinger-Ellison syndrome. It could be taken orally or intravenously. Scope of the Report: The worldwide market for Ranitidine is expected......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs